Exercise regimens, bone health and fracture prevention in later life: evidence still needed.

with sulfonylureas: a systematic review and meta-analysis. Diabetes Metab Res Rev 2014; 30: 11–22. 5. Roumie CL, Greevy RA, Grijalva CG, Hung AM, Liu X, Murff HJ et al. Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes. JAMA 2014; 311: 2288–96. 6. van Raalte DH, Ouwens DM, Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest 2009; 39: 81–93. 7. American Diabetes Association. Standards of medical care in diabetes 2015: older adults. Diabetes Care 2015; 38: S67–9. 8. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Eng J Med 2008; 358: 2545–59. 9. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Eng J Med 2008; 358: 2560–72. 10. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Eng J Med 2009; 360: 129–39. 11. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–9. 12. National Institute for Clinical and Healthcare Excellence. NICE Guideline CG 181. Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease. 2014. http://www.nice.org.uk/guidance/cg181/resources/ guidance-lipid-modification-cardiovascular-risk-assessment-andthe-modification-of-blood-lipids-for-the-primary-and-secondaryprevention-of-cardiovascular-disease-pdf (17 March 2015, date last accessed). 13. Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371: 117–25. 14. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Eng J Med 2008; 358: 580–91. 15. National Institute for Clinical and Healthcare Excellence. The Management of Type 2 Diabetes (CG87). 2009. http://www. nice.org.uk/guidance/cg87/resources/guidance-type-2-diabetespdf (17 March 2015, date last accessed). 16. American Diabetes Association. Cardiovascular disease and risk management. Diabetes Care 2015; 38: S49–57.